Best Hospitals in the USANewYork-Presbyterian Hospital
How GLP-1s Provide New Options to Manage Heart Disease
Dr. David Majure, a cardiologist specializing in heart failure at NewYork-Presbyterian and Weill Cornell Medicine, discusses the rise in using GLP-1s to treat cardiovascular disease. He breaks down the latest science on semaglutide and tirzepatide, and explains why GLP-1s could be a transformational therapy for patients with heart disease.
Source: NewYork-Presbyterian Hospital Channel – Full credit to the creator. Visit the channel, leave a like, and subscribe to stay updated with all the latest content!
